Goldman Sachs Maintains Buy Rating for GoodRx Holdings: Here’s What You Need To Know
Goldman Sachs has decided to maintain its Buy rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $30.00 to $12.00.
Shares of GoodRx Holdings are trading up 1.32% over the last 24 hours, at $8.07 per share.